Ansun Biopharma, Inc.   Report issue

For profit Phase 2 Phase 3
Founded: California City CA United States (2003)

Organization Overview

First Clinical Trial
2007
NCT00527865
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Ansun Biopharma, Inc.

Active Ingredients

Drugs in Phase 3 Trials (1)

das181 (11 trials)

Drugs in Phase 2 Trials (1)

lactose (4 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Asthma (Phase 1)

Bronchiectasis (Phase 1)

Communicable Diseases (Phase 3)

Infections (Phase 3)

Influenza, Human (Phase 2)

Paramyxoviridae Infections (Phase 3)

Respiratory Tract Infections (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 11
  • # of Trial APIs: 2